10-K
FORM 10-K
- Company
- PharmaCyte Biotech, Inc.
- Filed
- August 15, 2011
- Period of Report
- April 30, 2011
- Accession Number
- 0001262463-11-000129
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →